Intellia Therapeutics(NTLA) - 2024 Q1 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Results Conference Call May 9, 2024 8:00 AM ET Company Participants Ian Karp - Senior Vice President of Investor Relations and Corporate Communications John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Yanan Zhu - Wells Fargo Securities Maury Raycroft - Jefferies Troy Langford - TD Cowen Luca Issi - RBC Capital Kosta ...